Effect of syncytiotrophoblast microvillous membrane treatment on gene expression in human umbilical vein endothelial cells. 由 Hoegh, A, Tannetta, D, Sargent, I, Borup, R, Nielsen, F, Redman, C, Sørensen, S, Hviid, T

Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency. 由 van Wijk, R, van Solinge, W, Nerlov, C, Beutler, E, Gelbart, T, Rijksen, G, Nielsen, F

NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements. 由 Weischenfeldt, J, Damgaard, I, Bryder, D, Theilgaard-Mönch, K, Thoren, L, Nielsen, F, Jacobsen, SE, Nerlov, C, Porse, B

A gold-nanoparticle stoppered [2]rotaxane 由 Ulfkjær, A, Nielsen, F, Al-Kerdi, H, Ruβ, T, Nielsen, Z, Ulstrup, J, Sun, L, Moth-Poulsen, K, Zhang, J, Pittelkow, M

The personality trait openness is related to cerebral 5-HTT levels. 由 Kalbitzer, J, Frokjaer, V, Erritzoe, D, Svarer, C, Cumming, P, Nielsen, F, Hashemi, S, Baaré, W, Madsen, J, Hasselbalch, S, Kringelbach, M, Mortensen, E, Knudsen, G

Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased alpha 7 integrin, utrophin and associated glycoproteins. 由 Moghadaszadeh, B, Albrechtsen, R, Guo, LT, Zaik, M, Kawaguchi, N, Borup, R, Kronqvist, P, Schroder, H, Davies, K, Voit, T, Nielsen, F, Engvall, E, Wewer, U

Nomenclature for factors of the HLA-system 1977. 由 Albert, E, Amos, D, Bodmer, W, Ceppellini, R, Dausset, J, Kissmeyer-Nielsen, F, Mayr, W, Payne, R, van Rood, J, Terasaki, P, Trnka, Z, Walford, R

Nomenclature for factors of the HLA system-1977. 由 Albert, E, Amos, D, Bodmer, W, Ceppellini, R, Dausset, J, Kissmeyer-Nielsen, F, Mayr, W, Payne, R, van Rood, J, Terasaki, P, Trnka, Z, Walford, R

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis 由 Gregory, A, Kaur, G, Punwani, D, Felce, J, Davis, S, Fugger, L, Dendrou, C, Attfield, K, Haghikia, A, Lambert, L, Leach, O, Prömel, S, Gold, R, Xifara, D, McVean, G, Butter, F, Mann, M, Poschmann, G, Nielsen, F, Siegel, R, Bell, J

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. 由 Gregory, A, Dendrou, C, Attfield, K, Haghikia, A, Xifara, D, Butter, F, Poschmann, G, Kaur, G, Lambert, L, Leach, O, Prömel, S, Punwani, D, Felce, J, Davis, S, Gold, R, Nielsen, F, Siegel, R, Mann, M, Bell, J, McVean, G, Fugger, L